Enzyme activity and protein content of superoxide dismutase isozymes in human renal cell carcinoma

S Homma-Takeda1, A Sasaki, M Kikushima

  • 1Graduate School Doctoral Program in Medical Sciences, Institute of Community Medicine, University of Tsukuba, Ibaraki , Japan.

Research Communications in Molecular Pathology and Pharmacology
|January 5, 2002
PubMed

Insights

Human renal cell carcinoma shows reduced copper, zinc-superoxide dismutase (Cu,Zn-SOD) activity in cancerous tissues compared to normal kidney tissue. This suggests a weakened defense against free radical damage in these cancer cells.

Area of Science:

  • Biochemistry
  • Oncology
  • Molecular Biology

Background:

  • Renal cell carcinoma (RCC) is the most common type of kidney cancer.
  • Superoxide dismutase (SOD) isozymes are crucial antioxidant enzymes involved in cellular defense against reactive oxygen species.
  • Alterations in SOD isozyme activity may play a role in the development and progression of RCC.

Purpose of the Study:

  • To investigate the alterations in superoxide dismutase (SOD) isozyme activities and protein levels in human renal cell carcinoma tissues compared to non-cancerous renal tissues.
  • To determine the specific SOD isozymes affected in RCC and their potential contribution to oxidative stress.

Main Methods:

  • Enzyme activity assays were performed on cancerous and non-cancerous human renal tissues.
  • Immunoblot analysis was used to quantify the protein levels of SOD isozymes.
  • Comparison of enzyme activity and protein content was conducted for Cu,Zn-SOD and Mn-SOD.

Main Results:

  • Cu,Zn-SOD enzyme activity was significantly lower in cancerous renal tissues than in normal tissues.
  • Mn-SOD activity showed variations but no significant overall difference between cancerous and normal tissues.
  • Immunoblot analysis indicated that the decrease in Cu,Zn-SOD activity in cancerous tissues was disproportionately larger than the decrease in its protein content.

Conclusions:

  • The selective decrease in Cu,Zn-SOD activity in renal cell carcinoma suggests a compromised cytoplasmic antioxidant defense system.
  • Reduced Cu,Zn-SOD function may contribute to increased oxidative stress and cellular damage in RCC.
  • These findings highlight the potential role of Cu,Zn-SOD in the pathogenesis of renal cell carcinoma.

Related Concept Videos